Delivery Order 36C26026D0022-36C26026N0143
- Not listed
- The Department of Veterans Affairs Veterans Integrated Service Network 22 awarded a delivery order valued at $320,306.45 to RLS (USA) Inc. for the supply of radiopharmaceuticals. The contract, which was awarded on December 12, 2025, with an ultimate completion date of December 11, 2026, utilizes firm fixed price pricing and carries no set-aside designation. Performance will be conducted at RLS (USA) Inc.'s facility in Lake Mary, Florida. This delivery order falls under a larger indefinite...
- RLS (USA) Inc., a foreign-owned radiopharmacy company, has been awarded a delivery order valued at $356,461.75 by the Department of Veterans Affairs Veterans Integrated Service Network 5 for the supply of radiopharmaceuticals. The contract, awarded on April 1, 2025, carries a firm fixed price structure and an ultimate completion date of March 31, 2026. Performance will be executed from the contractor's facility in Lake Mary, Florida. This delivery order does not carry a set-aside designation and...
- The Department of Veterans Affairs, Veterans Integrated Service Network (VISN) 17 awarded a $990,211 delivery order for radiopharmaceuticals to RLS (USA) Inc., a foreign-owned radiopharmacy company specializing in nuclear medicine products for federal healthcare agencies. The contract employs firm fixed pricing and is not designated as a set-aside. RLS (USA) Inc. will perform work at its facility in Lake Mary, Florida, with an ultimate completion date of September 17, 2026. This delivery order...
- RLS (USA) Inc., a foreign-owned radiopharmacy company, has been awarded a delivery order valued at $91,658.40 by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 2 (VISN 2) for the supply of NETSPOT GA-68 (Gallium-68 Dotatate), a radiopharmaceutical used in nuclear medicine diagnostic imaging. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of December 31, 2026, and will be performed at the contractor's facility in...
- RLS (USA) Inc., a radiopharmacy company specializing in nuclear medicine products, received a delivery order award from the Department of Veterans Affairs (VA) Veterans Integrated Service Network 2 (VISN 2) on January 1, 2026, for the supply of NETSPOT GA-68 (Gallium-68 Dotatate), a radiopharmaceutical used in diagnostic imaging. This firm fixed-price delivery order carries a ceiling value of $91,658.40 and is scheduled for completion by December 31, 2026. The contract will be performed in...
- RLS (USA) Inc. was awarded a delivery order valued at $27,497.52 for NETSPOT GA-68 (Gallium-68 Dotatate) radiopharmaceuticals under the VA's Ordering Period 2 contract, effective September 1, 2025, with completion scheduled for December 31, 2025. The order will be fulfilled from the vendor's Lake Mary, Florida facility and represents a firm fixed-price procurement with no set-aside designation. This delivery order falls under a larger Indefinite Delivery Vehicle (IDV) established with Veterans...
- The Department of Veterans Affairs, Veterans Integrated Service Network 16, awarded a $2.53 million firm fixed-price purchase order to RLS (USA) Inc. for the supply of radiopharmaceuticals effective August 1, 2025, with completion targeted for May 31, 2026. The contract, which carries no set-aside designation, will be performed in New Orleans, Louisiana. RLS (USA) Inc., a foreign-owned radiopharmacy company operating 31 facilities across 18 states, specializes in providing time-sensitive...
- This is a delivery order contract awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 21 to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company. The contract, valued at $378,281.55, is for the delivery of radiopharmaceuticals to support nuclear medicine diagnostic services at VA medical centers. RLS (USA) Inc. is an established federal contractor, holding multiple Indefinite Delivery Vehicles (IDVs) with the VA and the Defense Health Agency...
- This is a definitive contract awarded by the Department of Veterans Affairs (VA) to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company, for the supply of radiopharmaceuticals and related services. The $878,999.37 firm-fixed price contract is not set aside and has an ultimate completion date of September 17, 2024. RLS (USA) Inc. specializes in providing a wide range of molecular imaging products, including medical isotopes and radiopharmaceuticals, to support nuclear medicine...
- This is a federal contract award to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company, by the Veterans Integrated Service Network 21 (VISN 21) of the U.S. Department of Veterans Affairs (VA). The contract is for the supply of radiopharmaceuticals and related supplies, with a ceiling value of $179,605.38 and a performance period through March 31, 2026. RLS (USA) Inc. is an established federal contractor, holding multiple Indefinite Delivery Vehicles (IDVs) with the VA and...
- 36C26026D0022Indefinite Delivery Contract
- 36C26026D0022-36C26026N0143Delivery Order
RLS (USA) Inc., a foreign-owned radiopharmacy company operating 31 facilities across 18 states, has been awarded a delivery order by Veterans Integrated Service Network 20 (VISN 20) for the supply of radiopharmaceuticals for nuclear medicine patients. The contract, effective January 1, 2026, carries a ceiling value of $493,958.37 under firm fixed-price terms and will be performed in Lake Mary, Florida, with a completion date of December 31, 2026. The award is not designated as a set-aside contract and represents a delivery order against an existing Indefinite Delivery Vehicle, enabling the VA to procure radiopharmaceutical products on an as-needed basis to support diagnostic imaging services at VA medical facilities. RLS (USA) Inc. provides a comprehensive range of radiopharmaceuticals essential for nuclear medicine imaging, including products such as gallium-67, fluorodeoxyglucose F-18, thallium-201, technetium-99m, and Gallium-68 Dotatate (NETSPOT). The company has established itself as a key supplier to federal healthcare agencies through multiple significant contracts with various VISN networks and the Defense Health Agency, delivering time-sensitive medical isotopes to VA medical centers and military treatment facilities nationwide. This delivery order reflects continued reliance on RLS (USA) Inc.'s specialized radiopharmaceutical distribution capabilities to support the VA's nuclear medicine diagnostic programs serving veterans.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $494.0k | 12/31/25 |